Press Room https://stage.mediaroom.com/sanofi/ MediaRoom AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session https://stage.mediaroom.com/sanofi/2026-03-28-AAD-new-results-from-Sanofis-amlitelimab-phase-3-studies-in-atopic-dermatitis-presented-in-late-breaking-research-session Sat, 28 Mar 2026 11:00:00 -0400 https://stage.mediaroom.com/sanofi/2026-03-28-AAD-new-results-from-Sanofis-amlitelimab-phase-3-studies-in-atopic-dermatitis-presented-in-late-breaking-research-session Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease https://stage.mediaroom.com/sanofi/2026-03-18-Sanofis-venglustat-earns-Breakthrough-Therapy-designation-in-the-US-for-type-3-Gaucher-disease Wed, 18 Mar 2026 02:00:00 -0400 https://stage.mediaroom.com/sanofi/2026-03-18-Sanofis-venglustat-earns-Breakthrough-Therapy-designation-in-the-US-for-type-3-Gaucher-disease Sanofi Becomes Official Supporter of the Boston World Cup 2026 Host City https://stage.mediaroom.com/sanofi/2026-02-25-Sanofi-Becomes-Official-Supporter-of-the-Boston-World-Cup-2026-Host-City Wed, 25 Feb 2026 09:00:00 -0500 https://stage.mediaroom.com/sanofi/2026-02-25-Sanofi-Becomes-Official-Supporter-of-the-Boston-World-Cup-2026-Host-City Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis https://stage.mediaroom.com/sanofi/2026-02-24-Sanofi-and-Regenerons-Dupixent-approved-in-the-US-as-the-first-and-only-medicine-for-allergic-fungal-rhinosinusitis Tue, 24 Feb 2026 09:02:00 -0500 https://stage.mediaroom.com/sanofi/2026-02-24-Sanofi-and-Regenerons-Dupixent-approved-in-the-US-as-the-first-and-only-medicine-for-allergic-fungal-rhinosinusitis Sanofi announces leadership evolution in Specialty Care Business Unit https://stage.mediaroom.com/sanofi/2026-02-17-Sanofi-announces-leadership-evolution-in-Specialty-Care-Business-Unit Tue, 17 Feb 2026 08:30:00 -0500 https://stage.mediaroom.com/sanofi/2026-02-17-Sanofi-announces-leadership-evolution-in-Specialty-Care-Business-Unit